Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

BACKGROUND: Fremanezumab, a fully humanized monoclonal antibody (IgG2Δa) that selectively targets calcitonin gene-related peptide (CGRP), is approved for migraine prevention in adults. Real-world data on the effectiveness of fremanezumab are limited. This retrospective, observational cohort study as...

Descripción completa

Detalles Bibliográficos
Autores principales: McAllister, Peter, Lamerato, Lois, Krasenbaum, Lynda J., Cohen, Joshua M., Tangirala, Krishna, Thompson, Stephen, Driessen, Maurice, Casciano, Julian, Dotiwala, Zenobia, Mauskop, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903530/
https://www.ncbi.nlm.nih.gov/pubmed/34930112
http://dx.doi.org/10.1186/s10194-021-01358-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903530/
https://www.ncbi.nlm.nih.gov/pubmed/34930112
http://dx.doi.org/10.1186/s10194-021-01358-9

Ejemplares similares